Lipid biosynthesis pathways as chemotherapeutic targets in kinetoplastid parasites

Parasitology

Volumn 114, Issue SUPPL. 1, 1997, Pages

  Urbina, J A ^a  

^a INSTITUTO VENEZOLANO DE INVESTIGACIONES CIENTÍFICAS   (Venezuela)

Author keywords

Leishmania; Lipids; Phospholipid biosynthesis inhibitors; Sterol biosynthesis inhibitors; Trypanosoma cruzi

Indexed keywords

2 (2,4 DIFLUOROPHENYL) 1 [3 [2 [4 (2,2,3,3 TETRAFLUOROPROPOXY)PHENYL]VINYL] 1,2,4 TRIAZOL 1 YL] 3 (1,2,4 TRIAZOL 1 YL) 2 PROPANOL; 4 [4 [4 [4 [[5 (2,4 DIFLUOROPHENYL)TETRAHYDRO 5 (1H 1,2,4 TRIAZOL 1 YLMETHYL)FURAN 3 YL]METHOXY]PHENYL] 1 PIPERAZINYL] PHENYL] 2,4 DIHYDRO 2 (1 ETHYL 2 HYDROXYPROPYL) 3H 1,2,4 TRIAZOLE 3 ONE; POSACONAZOLE; TRIAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL MODEL; CHAGAS DISEASE; CONFERENCE PAPER; FLAGELLATE; KINETOPLAST; LEISHMANIA; LEISHMANIASIS; LIPOGENESIS; MOUSE; NONHUMAN; PHOSPHOLIPID SYNTHESIS; PRIORITY JOURNAL; STEROL SYNTHESIS; TRYPANOSOMA CRUZI;

ANIMALS; ANTIPROTOZOAL AGENTS; CYTOCHROME P-450 ENZYME SYSTEM; DRUG DESIGN; KINETOPLASTIDA; LIPIDS; METHYLTRANSFERASES; OXIDOREDUCTASES; PARASITES; PHOSPHOLIPIDS; STEROLS; TRIAZOLES;

ALLIUM SATIVUM; ANIMALIA; LEISHMANIA BRAZILIENSIS; MASTIGOPHORA (FLAGELLATES); MURINAE; PNEUMOCYSTIS CARINII; TRYPANOSOMA; TRYPANOSOMA CRUZI;

EID: 0030921232     PISSN: 00311820     EISSN: None     Source Type: Journal    
DOI: 10.1017/s0031182097001194     Document Type: Article

References (73)

1. ACHTERBERG, V. & GERCKEN, G. (1987 a). Cytotoxicity of ester and ether lysophospholipids on Leishmania donovani promastigotes. Molecular and Biochemical Parasitology 23, 117-122.
2. ACHTERBERG, V. & GERCKEN, G. (1987b). Metabolism of ether lysophospholipids in Leishmania donovani promastigotes. Molecular and Biochemical Parasitology 26, 277-287.
3. APITZ-CASTRO, R., LEDEZMA, E., ESCALANTE, J. & JAIN, M. K. (1986). The molecular basis for the antiplatelet action of ajoene: direct interaction with the fibrinogen receptor. Biochemical and Biophysical Research Communications 141, 145-150.
4. ATKINSON, B. A., BOCANEGRA, R., COLOMBO, A. L. & GRAYBILL, J. R. (1994). Treatment of disseminated Torulopsis glabrata infection with D0870 and Amphotericin B. Antimicrobial Agents and Chemotherapy 38, 1604-1607.
5. BARRETT-BEE, K. & RYDER, N. S. (1992). Biochemical aspects of ergosterol biosynthesis inhibition. In Emerging Targets in Antibacterial and Antifungal Chemotherapy (ed. Sutcliffe, J. & Georgopapadakou, N. H.), pp. 410-436. New York and London: Chapman and Hall.
6. BARTLETT, M. S., QUEENER, S. F., SHAW, M. M., RICHARDSON, J. D. & SMITH, J. W. (1994). Pneumocystis carinii is resistant to imidazole antifungal agents. Antimicrobial Agents and Chemotherapy 38, 1859-1861.
7. BARTLETT, M. S. & SMITH, J. W. (1991). Pneumocystis carinii, an opportunistic in inmunocompromised patients. Clinical Microbiology Reviews 4, 137-149.
8. BEACH, D. H., GOAD, L. J. & HOLZ, G. G. JR. (1986). Effects of ketoconazole on sterol biosynthesis by Trypanosoma cruzi. Biochemical and Biophysical Research Communications 135, 851-856.
9. BEACH, D. H., GOAD, L. J. & HOLZ, G. G. JR. (1988). Effects of antimycotic azoles on growth and sterol biosynthesis of Leishmania promastigotes. Molecular and Biochemical Parasitology 31, 149-162.
10. BERMAN, J. D. (1981). Activity of imidazoles against Leishmania tropica in human macrophage cultures. American Journal of Tropical Medicine and Hygiene 30, 566-569.
11. BERMAN, J. D., GOAD, L. J., BEACH, D. H. & HOLZ, G. G. JR. (1986). Effects of ketoconazole on sterol biosynthesis by Leishmania mexicana mexicana amastigotes in murine macrophage tumor cells. Molecular and Biochemical Parasitology, 20, 85-92.
12. BERMAN, J. D., HOLZ, G. G. JR. & BEACH, D. H. (1984). Effects of ketoconazole on growth and sterol biosynthesis by Leishmania mexicana mexicana promastigotes in culture. Molecular Biochemical Parasitology 12, 1-13.
13. BLOCH, E., AHMAT, S., JAIN, M. K. & APITZ-CASTRO, R. (1986). Antithrombic organosulfur compounds from garlic: structural, mechanistic and synthetic studies. Journal of the American Chemical Society 108, 7045-7055.
14. BORELLI, D. (1987). A clinical trial of itraconazole in the treatment of mycoses and leishmaniasis. Review of Infectious Diseases 9 (suppl. 1), S57-S63.
15. BOYLE, F. T. (1990). Drug discovery: a chemist approach. In Chemotherapy of Fungal Infections (ed. Ryley, J. F.), pp. 3-30. Berlin and New York: Springer Verlag.
16. BOYLE, F. T., GILMAN, D. J., GRAVESTOCK, M. B. & WARDLEWORTH, J. M. (1988). Synthesis and structure-activity relationships of a novel antifungal agent ICI 195,739. In Antifungal Drugs (ed. St. Georgiev, V.), pp. 86-100. New York: Annals of the New York Academy of Sciences, vol. 544.
17. BRENER, Z., CANÇADO, J. R., GALVÃO, L. M., DA LUZ, Z. M. P., FILARDI, L. D. S., PEREIRA, M. E. S., SANTOS, L. M. T. & CANÇADO, C. B. (1993). An experimental and clinical assay with ketoconazole in the treatment of Chagas' disease. Memorias do Instituto Oswaldo Cruz 88, 149-153.
18. BRITTO, C., CARDOSO, M. A., MONTEIRO VANNI, C. M., HASSLOCHER-MORENO, A., XAVIER, S. S., OELEMANN, W., SANTORO, A., PIRMEZ, C., MORAL, C. M. & WINCKER, P. (1995). Polymerase chain reaction detection of Trypanosoma cruzi in human blood samples as a tool for diagnosis and treatment evaluation. Parasitology 110, 241-247.
19. BRITTO, C., CARDOSO, M. A., WINCKER, P. & MOREL, C. M. (1993). A simple protocol for the physical cleavage of Trypanosoma cruzi kinetoplast DNA present in blood samples and its use in polymerase chain reaction (PCR)-based diagnosis of chronic Chagas' disease. Memorias do Instituto Oswaldo Cruz 88, 171-172.
20. CARTLEDGE, J. D., DENNING, D., DUPONT, B., CLUMECK, N., DE WIT, S., HAWKINS, D. A. & GAZZARD, B. G. (1994). Treatment of fluconazole resistant oral candidosis with D0870 in patients with AIDS. ICAAC Abstracts 34, M89.
21. CLEMONS, K. V. & STEVENS, D. A. (1994). Utility of the triazole D0870 in the treatment of experimental systemic coccidiomycosis. Journal of Medical and Veterinary Mycology 32, 323-326.
22. CLEMONS, K. V. & STEVENS, D. A. (1995). Efficacy of the triazole D0870 in a murine model of systemic histoplasmosis. Antimicrobial Agents and Chemotherapy 39, 778-780.
23. CROFT, S. L., NEAL, R. A., PRENDERGAST, W. & CHAN, J. H. (1987). The activity of alkyl phosphorylcholines and related derivatives against Leishmania donovani. Biochemical Pharmacology 36, 2633-2636.
24. CROFT, S. L., NEAL, R. A., THORNTON, E. A. & HERRMANN, D. B. J. (1993). Antileishmanial activity of the ether phospholipid ilmofosine. Transactions of the Royal Society of Tropicial Medicine and Hygiene 87, 217-219.
25. CROFT, S. L., SNOWDON, D. & YARDLEY, V. (1996). The activities of four anticancer alkyllsophospholipids against Leishmania donovani, Trypanosoma cruzi and Trypanosoma brucei. Journal of Antimicrobial Chemotherapy 38, 1041-1047.
26. CUSHION, M. T., HARMSEN, A., MATSUMOTO, Y., STRINGER, J. R., WAKEFIELD, A. E. & YAMADA, M. (1994). Recent advances in the biology of Pneumocystis carinii. Journal of Medical Veterinary Mycology 32 (Suppl. 1), 217-228.
27. DAN, M., VERNER, E., EL-ON, J., ZUCKERMAN, F. & MICHAELI, D. (1986). Failure of oral ketoconazole to cure cutaneous ulcers caused by Leishmania braziliensis. Cutis 38, 198-199.
28. DEDET, J. P., JAMET, P., ESTERRE, P., GHIPPONI, P. M., GENIN, C. & LALANDE, G. (1986). Failure to cure Leishmania braziliensis guyanensis cutaneous Leishmaniasis with oral ketoconazole. Transactions of the Royal Society of Tropical Medicine and Hygiene 80, 296.
29. GOAD, L. J., BEBENS, R. L., MARK, J. J., BEACH, D. H. & HOLZ, G. G. JR. (1989). The activity of ketoconazole and other azoles against Trypanosoma cruzi: biochemistry and chemotherapeutic action in vivo. Molecular and Biochemical Parasitology 32, 179-190.
30. GOAD, L. J., HOLZ, G. G. JR. & BEACH, D. H. (1985). Sterols of ketoconazole-inhibited Leishmania mexicana mexicana promastigotes. Molecular and Biochemical Parasitology 15, 257-279.
31. HART, D. T., LAUWERS, W. J., WILLEMSENS, G., VANDEN BOSSCHE, H. & OPPERDOES, F. R. (1989). Perturbation of sterol biosynthesis by itraconazole and ketoconazole in Leishmania mexicana mexicana infected macrophages. Molecular and Biochemical Parasitology 33, 123-134.
32. HERRMANN, D. B. J. & NEUMANN, H. A. (1986). Cytotoxic ether phospholipids. Different affinities to lysophosphocholine acyltransferases in sensitive and resistant cells. Journal of Biological Chemistry 261, 7742-7747.
33. HILL, J. E., CHUNG, C., MCGRAW, P., SUMMERS, E. & HENRY, S. A. (1990). Biosynthesis and role of phospholipids in yeast membranes. In Biochemistry of Cell Walls and Membranes in Fungi (ed. Kuhn, P. J., Trinci, A. P. J., Jung, M. J., Goosey, M. W. & Copping, L. G.), pp. 245-260. Berlin: Springer-Verlag.
34. JOLLIFFE, D. S. (1986). Cutaneous Leishmaniasis from Belize-treatment with ketoconazole. Clinical and Experimental Dermatology 11, 62-68.
35. LARALDE, G., VIVAS, J. & URBINA, J. A. (1988). Concentration and time dependence of the effects of ketoconazole on growth and sterol biosynthesis in Trypanosoma (Schizotrypanum) cruzi epimastigotes. Acta Cientifica Venezolana 39, 140-146.
36. LAZARDI, K., URBINA, J. A. & DESOUZA, W. (1990). Ultrastructural alterations induced by two ergosterol biosynthesis inhibitors, ketoconazole and terbinafine, on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi. Antimicrobial Agents and Chemotherapy 34, 2097-2105.
37. LAZARDI, K., URBINA, J. A. & DESOUZA, W. (1991). Ultrastructural alterations induced by ICI 195,739, a bis triazole with strong antiproliferative action against Trypanosoma (Schizotrypanum) cruzi. Antimicrobial. Agents and Chemotherapy 35, 736-740.
38. LYR, H. (1995). Modern Selective Fungicides. (2nd edn.) Jena: Gustav Fisher Verlag.
39. MALDONADO, R. A., MOLINA, J., PAYARES, G. & URBINA, J. A. (1993). Experimental chemotherapy with combinations of ergosterol biosynthesis inhibitors in murine models of Chagas' disease. Antimicrobial Agents and Chemotherapy 37, 1353-1359.
40. MASUR, H. (1992). Prevention and treatment of Pneumocystis pneumonia. New England Journal of Medicine 327, 1853-1860.
41. MCCABE, R. E. (1988). Failure of ketoconazole to cure chronic murine Chagas' disease. Journal of Infectious Diseases 158, 1408-1409.
42. MCCABE, R. E., REMINGTON, J. S. & ARAUJO, F. G. (1984). Ketoconazole inhibition of intracellular multiplication of Trypanosoma cruzi and protection against a lethal infection with the organism. Journal of Infectious Diseases 150, 594-601.
43. MCCABE, R. E., REMINGTON, J. S. & ARAUJO, F. G. (1986). In vitro and in vivo effects of itraconazole against Trypanosoma crusi. American Journal of Tropical Medicine and Hygiene 35, 280-284.
44. MCCABE, R. E., REMINGTON, J. S. & ARAUJO, F. J. (1987). Ketoconazole promotes parasitological cure of mice infected with Trypanosoma cruzi. Transactions of the Royal Society of Tropical Medicine and Hygiene 81, 613-615.
45. MERCER, E. I. (1993). Inhibitors of sterol biosynthesis and their applications. Progress in Lipid Research 32, 357-116.
46. MOREIRA, A. A. B., DESOUZA, H. B. W. T., AMATO, NETO, V., MATSUBARA, L., PINTO, P. L. S., TOLEZANO, J. E., NUNES, E. V. & OKUMURA, M. (1992). Avaliacão da ativadade terapêutica do itraconazol nas infecçoes crônicas, experimental e humana, pelo Trypanosoma cruzi. Revista do Instituto de Medicina Tropical do Sao Paulo 34, 177-180.
47. NAVIN, T. R., ARANA, B. A., ARANA, F. E., BERMAN, J. D. & CHAJON, J. F. (1992). Placebo-controlled clinical trial of sodium stibogluconate (Pentostam) versus ketoconazole for treating cutaneous Leishmanasis in Guatemala. Journal of Infectious Diseases 165, 528-534.
48. NORTON, S. A., FRANKENBURG, S. & KLAUS, S. N. (1992). Cutaneous leishmaniasis acquired during military service in the Middle East. Archives of Dermatology 128, 83-87.
49. OEHLSCHLAGER, A. C. & CZYZEWSKA, E. (1992). Rationally designed inhibitors of sterol biosynthesis. In Emerging Targets in Antibacterial and Antifungal Chemotherapy (ed. Sutcliffe, J. & Georgopapadakou, N. H.), pp. 437-475. New York and London: Chapman and Hall.
50. PERFECT, J. R., COX, G. M., DODGE, R. K. & SCHELL, W. A. (1996). In vitro and In vivo efficacies of the azole SCH56592 against Cryptococcus neoformans. Antimicrobial Agents and Chemotherapy 40, 1910-1913.
51. RAETHER, W. & SEIDENATH, H. (1984). Ketoconazole and other potent antimycotic azoles exhibit pronounced activity against Trypanosoma cruzi, Plasmodium berghei and Entamoeba histolytica in vivo. Zeitschrift für Parasitenkunde 70, 135-138.
52. RAHIER, A., TATON, M. & BENVENISTE, P. (1990). Inhibition of sterol biosynthesis in higher plants by analogues of high energy carbocationic intermediates. In Biochemistry of Cell Walls and Membranes in Fungi (ed. Kuhn, P. J., Trinci, A. P. J., Jung, M. J., Goosey, M. W. & Copping, L. G.), pp. 205-221. Berlin and Heidelberg: Springer Verlag.
53. RANGEL, H., DAGER, F., HERNANDEZ, A., LIENDO, A. & URBINA, J. A. (1996). Naturally azole-resistant Leishmania braziliensis promastigotes are rendered susceptible in the presence of terbinafine. A comparative study with azole-susceptible. Leishmania mexicana. Antimicrobial Agents and Chemotherapy 40, 2785-2791.
54. ROBSON, G. D., WIEBE, M., KUHN, P. J. & TRINCI, A. P. J. (1990). Inhibitors of phospholipid biosynthesis. In Biochemistry of Cell Walls and Membranes in Fungi (ed. Kuhn, P. J., Trinci, A. P. J., Jung, M. J., Goosey, M. W. & Copping, L. G.), pp. 245-281. Berlin: Springer-Verlag.
55. RYLEY, J. F., MCGREGOR, S. & WILSON, R. G. (1988). Activity of ICI 195,739 - a novel orally active bistriazole - in rodent models of fungal and protozoal infections. In Antifungal Drugs (ed. St. Georgiev, V.), pp. 310-328. New York: Annals of the New York Academy of Sciences, vol. 544.
56. SAENZ, R. E., PAZ, H. & BERMAN, J. D. (1990). Efficacy of ketoconazole against Leishmania braziliensis panamensis cutaneous leishmaniasis. American Journal of Medicine 89, 147-155.
57. SAN BLAS, G., SAN BLAS, F., GIL, F., MARINO, L. & APITZ-CASTRO, R. (1989). Inhibition of growth of the dimorphic fungus Paracoccidioides brasiliensis by ajoene. Antimicrobial Agents and Chemotherapy 33, 1641-1644.
58. SMULIAN, A. G. & WALZER, P. D. (1992). The biology of Pneumocystis carinii. Critical Reviews in Microbiology 18, 191-216.
59. SUGAR, A. M. & LIU, X.-P. (1996). In vitro and in vivo activities of SCH 56592 against Blastomyces dermatitidis. Antimicrobial Agents and Chemotherapy 40, 1314-1316.
60. URBINA, J. A., LAZARDI, K., AGUIRRE, T., PARIS, M. M. & PIRAS, R. (1988). Antiproliferative synergism of the allylamine SF-86327 and ketoconazole on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi. Antimicrobial Agents and Chemotherapy 32, 1237-1242.
61. URBINA, J. A., LAZARDI, K., AGUIRRE, T., PIRAS, M. M. & PIRAS, R. (1991). Antiproliferative effects and mechanism of action of ICI 195,739, a novel bis-triazole derivative, on epimastigotes and amastigotes of Trypanosoma (Schizotrypanuni) cruzi. Antimicrobial Agents and Chemotherapy 35, 730-735.
62. URBINA, J. A., LAZARDI, K., MARCHAN, E., VISBAL, G., AGUIRRE, T., PIRAS, M. M., PIRAS, R., MALDONADO, R. A., PAYARES, G. & DESOUZA, W. (1993 a). Mevinolin (lovastatin) potentiates the antiproliferative effects of ketoconazole and terbinafine against Trypanosoma (Schisotrypanum) cruzi: in vivo and in vitro studies. Antimicrobial Agents and Chemotherapy 37, 580-591.
63. URBINA, J. A., MARCHAN, E., LAZARDI, K., VISBAL, G., APITZ-CASTRO, R., GIL, F., AGUIRRE, T., PIRAS, M. M. & PIRAS, R. (1993b) Inhibition of phosphatidylcholine biosynthesis and cell proliferation in Trypanosoma cruzi by ajoene, an antiplatelet compound isolated from garlic. Biochemical Pharmacology 45, 2381-2387.
64. URBINA, J. A., PAYARES, G., MOLINA, J., SANOJA, C., LIENDO, A., LAZARDI, K., PIRAS, M. M., PIRAS, R., PEREZ, N., WINCKER, P. & RYLEY, J. F. (1996a). Cure of short-and long-term experimental Chagas' disease using D0870. Science 273, 969-971.
65. 24(25)-sterol methyl transferase inhibitors and their combinations with ketoconazole. Molecular and Biochemical Parasitology 79, 199-210.
66. 24(25) sterol methyl transferase inhibitors on Trypanosoma (Schizotrypanum) cruzi: in vitro and in vivo studies. Chemotherapy 42, 294-307.
67. 24(25)-sterol methyl transferase block sterol synthesis and cell proliferation in Pneumocystis carinii. Antimocrobial Agents and Chemotherapy (in press).
68. URCUYO, F. G. & ZAIAS, N. (1982). Oral ketoconazole in the treatment of leishmaniasis. International Journal of Dermatology 21, 414-416.
69. WEINRAUCH, L., LIVISHIN, R. & EL-ON, J. (1987). Ketoconazole in cutaneous Leishmaniasis. British Journal of Dermatology 117, 666-667.
70. WINCKER, P., BRITTO, C., BORGES-PEREIRA, J., CARDOSO, M. A., OELEMANN, W. & MOREL, C. M. (1994). Use of a simplified polymerase chain reaction procedure to detect Trypanosoma cruzi in blood samples from chronic Chagas'ic patients in a rural endemic area. American Journal of Tropical Medicine and Hygiene 51, 771-777.
71. YAMADA, H., TSUDA, T., WATANABE, T., OHASHI, M., MURAKAMI, K. & MOCHIZUKI, H. (1993). In vitro and in vivo antifungal activities of D0870, a new triazole agent. Antimicrobial Agents and Chemotherapy 37, 2412-2417.
72. YAMAGUCHI, H., KOBAYASHI, G. S. & TAKAHASHI, H. (1992). Recent Progress in Antifungal Chemotherapy. New York: Marcell Dekker.
73. YOSHIDA, S., KASUGA, S., HAYASHI, N., USHIROGUCHI, T., MATSUURA, H. & NAKAGAWUA, N. (1987). Antifungal activity of ajoene derived from garlic. Applied and Environmental Microbiology 53, 615-617.